Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.

作者: LinZhang Huang , BaoYan Fan , Ang Ma , Philip W. Shaul , HaiBo Zhu

DOI: 10.1194/JLR.M054742

关键词: CholesterolInternal medicineABCA1BiologyReverse cholesterol transportEndocrinologyHigh-density lipoproteinDownregulation and upregulationEffluxApolipoprotein ETransport protein

摘要: ABCA1 plays a key role in the initial lipidation of apoA-I, which generates circulating HDL cholesterol. Whereas it is known that transcriptional upregulation promotes formation and reverse cholesterol transport (RCT), not how inhibition protein degradation impacts function. Employing small molecule triacetyl-3-hydroxyphenyladenosine (IMM-H007), we determined attenuation affects efflux capacity, RCT, atherosclerotic lesion formation. Pulse-chase analysis revealed IMM-H007 inhibits facilitates its cell-surface localization macrophages, additional studies macrophages showed thereby efflux. treatment Paigen diet-fed mice caused an increase level, increased capacity HDL, enhanced vivo RCT from to plasma, liver, feces. Furthermore, suppression by reduced plaque apoE(-/-) mice. Thus, via effects on both ABCA1-expressing cells function, attenuates atherogenesis. potentially represents lead compound for development agents augment

参考文章(37)
J.R. Schultz, E.L. Gong, M.R. McCall, A.V. Nichols, S.M. Clift, E.M. Rubin, Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice. Journal of Biological Chemistry. ,vol. 267, pp. 21630- 21636 ,(1992) , 10.1016/S0021-9258(19)36658-X
E. Maganto‐Garcia, M. Tarrio, A.H. Lichtman, Mouse models of atherosclerosis. Current protocols in immunology. ,vol. 96, ,(2012) , 10.1002/0471142735.IM1524S96
Peng Guo, Ze-qin Lian, Ling-hui Sheng, Chong-ming Wu, Jian Gao, Jin Li, Yao Wang, Yan-shen Guo, Hai-bo Zhu, None, The adenosine derivative 2',3',5'-tri-O-acetyl-N6-(3-hydroxylaniline) adenosine activates AMPK and regulates lipid metabolism in vitro and in vivo. Life Sciences. ,vol. 90, pp. 1- 7 ,(2012) , 10.1016/J.LFS.2011.09.001
Noriyuki Iwamoto, Rui Lu, Nobukiyo Tanaka, Sumiko Abe-Dohmae, Shinji Yokoyama, Calmodulin Interacts With ATP Binding Cassette Transporter A1 to Protect From Calpain-Mediated Degradation and Upregulates High-Density Lipoprotein Generation Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 30, pp. 1446- 1452 ,(2010) , 10.1161/ATVBAHA.110.203927
Neil Ruderman, Marc Prentki, AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome Nature Reviews Drug Discovery. ,vol. 3, pp. 340- 351 ,(2004) , 10.1038/NRD1344
Margarita de la Llera-Moya, Denise Drazul-Schrader, Bela F. Asztalos, Marina Cuchel, Daniel J. Rader, George H. Rothblat, The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 30, pp. 796- 801 ,(2010) , 10.1161/ATVBAHA.109.199158
Peter W.F. Wilson, High-density lipoprotein, low-density lipoprotein and coronary artery disease. American Journal of Cardiology. ,vol. 66, ,(1990) , 10.1016/0002-9149(90)90562-F
Natalie Fournier, Nesrine Attia, Delphine Rousseau-Ralliard, Benoît Vedie, Frédéric Destaillats, Alain Grynberg, Jean-Louis Paul, Deleterious impact of elaidic fatty acid on ABCA1-mediated cholesterol efflux from mouse and human macrophages Biochimica et Biophysica Acta. ,vol. 1821, pp. 303- 312 ,(2012) , 10.1016/J.BBALIP.2011.10.005
Omar M. Khan, Murali K. Akula, Kristina Skålen, Christin Karlsson, Marcus Ståhlman, Stephen G. Young, Jan Borén, Martin O. Bergo, Targeting GGTase-I Activates RHOA, Increases Macrophage Reverse Cholesterol Transport, and Reduces Atherosclerosis in Mice Circulation. ,vol. 127, pp. 782- 790 ,(2013) , 10.1161/CIRCULATIONAHA.112.000588